Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Hematologic Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Communication Devices for People with Disabilities × Clear all
NCT05341622 2024-07-24

Mailed FIT Outreach 2022

Abramson Cancer Center at Penn Medicine

Phase NA Completed
5,460 enrolled 20 charts
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT04081298 2023-07-03

MiVSEEV

Fred Hutchinson Cancer Center

Phase NA Terminated
20 enrolled 34 charts
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡